All Publications

Phase II study of tolerance and efficacy of hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and paclitaxel (taxol) and amifostine (ethyol) in head and neck squamous cell carcinomas: A-3 protocol

2005

Article

Additional authors and institutional affiliations

American Journal of Clinical Oncology (2005) 28(5):449-55

Available to BHSF community via local IP address or BHSF login.

COinS